| Code | CSB-MP360437HU |
| Abbreviation | Recombinant Human PLAU protein (Active) |
| MSDS | |
| Size | $156 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
Urokinase-type plasminogen activator drives fibrinolysis and extracellular matrix remodeling in tumor invasion and metastasis, making its enzymatic characterization central to cancer biology and therapeutic target validation. This full-length mature protein (aa 21–431) demonstrates specific activity above 2000 pmol/min/μg when activated by plasmin and assayed with the fluorogenic substrate Z-GGR-AMC, providing quantitative performance suitable for kinetic parameter analysis including Km, Vmax, and kcat/Km determination. The C-terminal 10×His tag preserves catalytic site accessibility while enabling straightforward purification, and the greater than 95% purity combined with endotoxin levels below 1.0 EU/μg supports accurate inhibitor screening, IC50 determination, and drug candidate evaluation where contaminants would confound dose-response measurements. Researchers can apply this validated enzyme as a positive control in protease-linked assays or for substrate specificity profiling to dissect PLAU's role in plasminogen activation cascades.
There are currently no reviews for this product.